NASDAQ
Canntab Therapeutics Limited (CTABF) has a current ratio of 0.57x as of Monday, May 25, 2026. This represents a 91.52% decrease compared to its 12-month average of 6.75x. The current ratio measures a company's ability to cover short-term obligations by comparing current assets to current liabilities.
No price data available for this timeframe.